Equillium Inc

General ticker "EQ" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $24.8M

Equillium Inc does not follow the US Stock Market performance with the rate: -12.0%.

Estimated limits based on current volatility of 4.4%: low 0.58$, high 0.63$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.49$, 1.36$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.77$, 1.86$]

Financial Metrics affecting the EQ estimates:

  • Negative: Non-GAAP EPS, $ of -0.39 <= 0.10
  • Negative: Operating profit margin, % of -28.70 <= 1.03
  • Negative: Operating cash flow per share per price, % of -50.66 <= 2.35
  • Negative: negative Net income
  • Positive: -0.96 < Investing cash flow per share, $ of -0.14
  • Positive: Interest expense per share, $ of 0.01 <= 0.14
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term EQ quotes

Long-term EQ plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $15.76MM $36.08MM
Operating Expenses $37.79MM $77.83MM $50.61MM
Operating Income $-37.79MM $-62.08MM $-14.52MM
Non-Operating Income $-1.27MM $-0.35MM $1.77MM
Interest Expense $1.07MM $1.05MM $0.49MM
R&D Expense $26.38MM $37.55MM $37.04MM
Income(Loss) $-39.05MM $-62.43MM $-12.76MM
Taxes $0.00MM $0.00MM $0.58MM
Profit(Loss) $-39.05MM $-62.43MM $-13.34MM
Stockholders Equity $66.50MM $31.94MM $22.57MM
Assets $85.41MM $78.42MM $50.53MM
Operating Cash Flow $-32.08MM $-8.73MM $-21.78MM
Capital expenditure $0.06MM $0.28MM $0.05MM
Investing Cash Flow $27.41MM $18.68MM $-4.76MM
Financing Cash Flow $31.06MM $-1.22MM $-9.23MM
Earnings Per Share* $-1.35 $-3.19 $-0.38

* EPS are Split Adjusted, recent splits may be reflected with a delay.